Bearish
The article mentions that investors in APUS have an opportunity to join a fraud investigation against Apimeds Pharmaceuticals US, Inc. with The Schall...
Bearish
Apimeds Pharmaceuticals US (APUS) received a notice of noncompliance from NYSE American on April 17, 2026, for failing to file its 2025 Form 10-K. The...
Bearish
The Rosen Law Firm has announced an investigation into potential securities claims against Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS), all...
The Rosen Law Firm has announced an investigation into potential securities claims against Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS). The...